This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock SRNG vs. PRME, IKT, PLX, IZTC, ACHL, BLUE, CRTX, ZIVO, CYTH, and FNCHShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include Prime Medicine (PRME), Inhibikase Therapeutics (IKT), Protalix BioTherapeutics (PLX), Invizyne Technologies (IZTC), Achilles Therapeutics (ACHL), bluebird bio (BLUE), Cortexyme (CRTX), ZIVO Bioscience (ZIVO), Cyclo Therapeutics (CYTH), and Finch Therapeutics Group (FNCH). Soaring Eagle Acquisition vs. Its Competitors Prime Medicine Inhibikase Therapeutics Protalix BioTherapeutics Invizyne Technologies Achilles Therapeutics bluebird bio Cortexyme ZIVO Bioscience Cyclo Therapeutics Finch Therapeutics Group Soaring Eagle Acquisition (NASDAQ:SRNG) and Prime Medicine (NYSE:PRME) are both biological products, except diagnostic industry companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. Is SRNG or PRME more profitable? Soaring Eagle Acquisition's return on equity of 0.00% beat Prime Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Soaring Eagle AcquisitionN/A N/A N/A Prime Medicine N/A -107.87%-74.97% Do analysts prefer SRNG or PRME? Prime Medicine has a consensus target price of $10.08, indicating a potential upside of 131.80%. Given Prime Medicine's stronger consensus rating and higher probable upside, analysts plainly believe Prime Medicine is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Prime Medicine 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75 Do institutionals and insiders believe in SRNG or PRME? 41.2% of Soaring Eagle Acquisition shares are owned by institutional investors. Comparatively, 70.4% of Prime Medicine shares are owned by institutional investors. 22.9% of Prime Medicine shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to SRNG or PRME? In the previous week, Prime Medicine had 8 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 8 mentions for Prime Medicine and 0 mentions for Soaring Eagle Acquisition. Prime Medicine's average media sentiment score of 0.92 beat Soaring Eagle Acquisition's score of 0.20 indicating that Prime Medicine is being referred to more favorably in the news media. Company Overall Sentiment Soaring Eagle Acquisition Neutral Prime Medicine Positive Which has better valuation & earnings, SRNG or PRME? Soaring Eagle Acquisition has higher earnings, but lower revenue than Prime Medicine. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoaring Eagle AcquisitionN/AN/AN/AN/AN/APrime Medicine$3.85M152.12-$198.13M-$1.61-2.70 SummaryPrime Medicine beats Soaring Eagle Acquisition on 9 of the 11 factors compared between the two stocks. Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$2.15B$216.39M$7.89B$9.10BDividend YieldN/AN/A10.93%4.02%P/E RatioN/AN/A64.2720.26Price / SalesN/A253.1121,123.13153.06Price / CashN/A22.4436.3557.67Price / BookN/A6.153.765.49Net IncomeN/A-$96.61M$4.23B$250.45M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$9.98-7.5%N/A+3,016.8%$2.15BN/A0.00N/AGap DownPRMEPrime Medicine3.9106 of 5 stars$3.16+2.9%$10.08+219.1%-23.8%$414.89M$3.85M-1.54234High Trading VolumeIKTInhibikase Therapeutics1.2185 of 5 stars$1.89+2.2%$6.50+243.9%+27.1%$140.51MN/A-0.716PLXProtalix BioTherapeutics2.8321 of 5 stars$1.55+3.0%$15.00+870.9%+23.1%$122.99M$59.76M-11.88200News CoverageIZTCInvizyne TechnologiesN/A$9.91-2.8%N/AN/A$103.16MN/A0.0029Gap UpACHLAchilles TherapeuticsN/A$1.48flatN/AN/A$60.83MN/A-0.90250BLUEbluebird bio1.5705 of 5 stars$4.97flat$44.60+797.4%N/A$48.67M$103.95M-0.13520CRTXCortexymeN/A$1.61+0.6%N/A+109.7%$48.54MN/A-0.5455ZIVOZIVO BioscienceN/A$11.99flatN/A+59.8%$45.72M$15.85K-2.4610CYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809FNCHFinch Therapeutics Group0.7782 of 5 stars$13.08-0.9%N/A+791.6%$21.00MN/A-1.48190News CoveragePositive News Related Companies and Tools Related Companies PRME Alternatives IKT Alternatives PLX Alternatives IZTC Alternatives ACHL Alternatives BLUE Alternatives CRTX Alternatives ZIVO Alternatives CYTH Alternatives FNCH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNG) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRNG Stock Alerts